Dr. William Morice provides insights on the evolving technologies in medicine - Insights
In a Fierce Healthcare article, Dr. William Morice highlights AI, digital pathology, and mass spectrometry as key advancements revolutionizing healthcare diagnostics and treatment.
Preparing for Respiratory Viruses: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss...
William Morice II, M.D., Ph.D., considers the future of diagnostics - Insights
Dr. Morice talks about what lies ahead for laboratory medicine and how the opportunities and challenges in the field are intertwined.
A downward spiral undone: Jon Bratsch - Insights
Lying in an ICU bed as sick as he could get, Jon Bratsch thought he was past the point of no return. But when a Mayo Clinic Laboratories’ test revealed the source of his dire symptoms, everything changed. Today, Jon’s back to the life and...
Reclaiming her joy: Joy Carol - Insights
A tenacious fighter, Joy Carol never lost hope that a mysterious condition that had stripped her of her ability to move would be identified. Hope turned into reality when a Mayo Clinic Laboratories test identified the cause of her illness...
MCL @Work: Jane Hermansen - Insights
Outreach manager Jane Hermansen regards Mayo Clinic as the pinnacle of healthcare. Having spent her formative years in Minnesota, she was inspired by her uncle Roger to embark on a path as a laboratory scientist. Presently, she oversees the...
MASTERMIND: A Smarter Search for Microbial Diagnostics - Insights
In the war against microbes, human beings are vastly outnumbered—and losing the weapons race.
Understanding the difference between benign and malignant adrenal tumors has alway been difficult; this new assay will assist with this medical challenge.
Mayo Clinic Laboratories’ novel lupus testing, offered in partnership with Progentec Diagnostics, can help characterize disease activity and predict disease flares.
Mayo Clinic Laboratories’ novel lupus testing, offered in partnership with Progentec Diagnostics, can help characterize disease activity and predict disease flares.